ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Using integrated analysis from multicentre studies to identify RNA methylation-related lncRNA risk stratification systems for glioma

Huang, Fanxuan; Wang, Xinyu; Zhong, Junzhe; Chen, Hao; Song, Dan; Xu, Tianye; Tian, Kaifu; Sun, Penggang; Sun, Nan; Qin, Jie; Song, Yu; Ma, Wenbin; Liu, Yuxiang; Yu, Daohan; Meng, Xiangqi; Jiang, Chuanlu; Xuan, Hanwen; Qian, Da*; Cai, Jinquan*哈尔滨医科大学; 苏州大学; 1
Cancer Cell International2023-8-5DOI: 10.1186/s12935-023-03001-w
13阅读
引用收藏
分享

摘要

BackgroundN6-methyladenosine (m6A), 5-methylcytosine (m5C) and N1-methyladenosine (m1A) are the main RNA methylation modifications involved in the progression of cancer. However, it is still unclear whether RNA methylation-related long noncoding RNAs (lncRNAs) affect the prognosis of glioma.MethodsWe summarized 32 m6A/m5C/m1A-related genes and downloaded RNA-seq data and clinical information from The Cancer Genome Atlas (TCGA) database. Differential expression analysis and weighted gene co-expression network analysis (WGCNA) were used to identify differentially expressed (DE-) RNA methylation-related lncRNAs in order to construct a prognostic signature of glioma and in order to determine their correlation with immune function, immune therapy and drug sensitivity. In vitro and in vivo assays were performed to elucidate the effects of RNA methylation-related lncRNAs on glioma.ResultsA total of ten RNA methylation-related lncRNAs were used to construct a survival and prognosis signature, which had good independent prediction ability for patients. It was found that the high-risk group had worse overall survival (OS) than the low-risk group in all cohorts. In addition, the risk group informed the immune function, immunotherapy response and drug sensitivity of patients with glioma in different subgroups. Knockdown of RP11-98I9.4 and RP11-752G15.8 induced a more invasive phenotype, accelerated cell growth and apparent resistance to temozolomide (TMZ) both in vitro and in vivo. We observed significantly elevated global RNA m5C and m6A levels in glioma cells.ConclusionOur study determined the prognostic implication of RNA methylation-related lncRNAs in gliomas, established an RNA methylation-related lncRNA prognostic model, and elucidated that RP11-98I9.4 and RP11-752G15.8 could suppress glioma proliferation, migration and TMZ resistance. In the future, these RNA methylation-related lncRNAs may become a new choice for immunotherapy of glioma.

学科与关键词

关键词
ChemotherapyGliomaImmunotherapyLncRNAsPrognosisRNA methylation
相关
加载中…
  • 5-Methylcytosine Related LncRNAs Reveal Immune Characteristics, Predict Prognosis and Oncology Treatment Outcome in Lower-Grade Gliomas
    Zhang, Jiheng; Wang, Nan; Wu, Jiasheng; Gao, Xin; Zhao, Hongtao; Liu, Zhihui; Yan, Xiuwei; Dong, Jiawei; Wang, Fang; Ba, Yixu; Ma, Shuai; Jin, Jiaqi; Du, Jianyang; Ji, Hang*; Hu, Shaoshan*Frontiers in Immunology, 2022, 13: 844778.被引 15
  • Identification of an N6-methyladenosine (m6A)-related signature associated with clinical prognosis, immune response, and chemotherapy in primary glioblastomas
    Cai, Zhiqiang; Zhang, Jianbo*; Liu, Ziying; Su, Jiahao; Xu, Jing; Li, Zhenjun; Meng, Hongliang; Zhang, Heng; Huang, Minjie; Zhao, Donghai; Duan, Chuanzhi; He, Xuying*Annals of Translational Medicine, 2021, 9(15): 1241.被引 10
  • N6-methyladenine-related genes affect biological behavior and the prognosis of glioma
    Qu, Shanqiang; Chen, Zhixin; Liu, Bin; Liu, Jin*; Wang, Huafu*Cancer Medicine, 2021, 10(1): 98-108.被引 19
查看全部 →

发表信息

论文状态
公开发表
期刊
Cancer Cell International
发表日期
2023-08-05
卷期
第 23 卷, 第 1 期
页码
156
DOI
10.1186/s12935-023-03001-w
语言
ENGLISH
成果收录
SCIE

作者

  • H

    Huang, Fanxuan (第一作者)

    2 · harbin med univ

  • W

    Wang, Xinyu

    2 · harbin med univ

查看全部 19 位作者收起作者
  • Z

    Zhong, Junzhe

    2 · harbin med univ

  • C

    Chen, Hao

    2 · harbin med univ

  • S

    Song, Dan

    2 · harbin med univ

  • X

    Xu, Tianye

    2 · harbin med univ

  • T

    Tian, Kaifu

    2 · harbin med univ

  • S

    Sun, Penggang

    2 · harbin med univ

  • S

    Sun, Nan

    2 · harbin med univ

  • Q

    Qin, Jie

    2 · harbin med univ

  • S

    Song, Yu

    2 · harbin med univ

  • M

    Ma, Wenbin

    2 · harbin med univ

  • L

    Liu, Yuxiang

    2 · harbin med univ

  • Y

    Yu, Daohan

    2 · harbin med univ

  • M

    Meng, Xiangqi

    2 · harbin med univ

  • J

    Jiang, Chuanlu

    2 · harbin med univ

  • X

    Xuan, Hanwen

    2 · harbin med univ

  • Q

    Qian, Da (通讯)

    1 · soochow univ

  • C

    Cai, Jinquan (通讯)

    2 · harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417